Cardiff Oncology, Inc.(CRDF)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CRDF Cardiff Oncology, Inc.

交易中 05-01 10:52:53 EDT

2.77

+0.03

+1.09%

最高2.77	最低2.66	成交量8.60万
今开2.75	昨收2.74	日振幅4.01%
总市值1.84亿	流通市值1.59亿	总股本6,652万
成交额23.38万	换手率0.15%	流通股本5,738万
市净率2.22	ROE-59.51%	每股收益-0.95
52周最高5.64	52周最低2.01	市盈率-2.90
股息0.00	股息收益率0.00	ROA-34.01%

北京优虎网络科技有限公司

{"stockData":{"symbol":"CRDF","market":"US","secType":"STK","nameCN":"Cardiff Oncology, Inc.","latestPrice":2.77,"timestamp":1746111137779,"preClose":2.74,"halted":0,"volume":86029,"delay":0,"floatShares":57384195,"shares":66524294,"eps":-0.953934,"marketStatus":"交易中","change":0.03,"latestTime":"05-01 10:52:51 EDT","open":2.75,"high":2.77,"low":2.66,"amount":233777.03701769997,"amplitude":0.040146,"askPrice":2.77,"askSize":472,"bidPrice":2.76,"bidSize":1009,"shortable":3,"etf":0,"ttmEps":-0.953934,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1746129600000},"marketStatusCode":2,"adr":0,"listingDate":1059624000000,"exchange":"NASDAQ","adjPreClose":2.74,"preHourTrading":{"tag":"盘前","latestPrice":2.74,"preClose":2.74,"latestTime":"08:37 EDT","volume":2,"amount":5.48,"timestamp":1746103046528},"postHourTrading":{"tag":"盘后","latestPrice":2.88,"preClose":2.74,"latestTime":"18:47 EDT","volume":2049,"amount":5656.26,"timestamp":1746053267982},"volumeRatio":0.49967,"impliedVol":1.2488,"impliedVolPercentile":0.388},"requestUrl":"/m/hq/s/CRDF","defaultTab":"news","newsList":[{"id":"2531518337","title":"Cardiff Oncology, Inc.盘中异动 早盘急速跳水5.02%报2.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531518337","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531518337?lang=zh_cn&edition=full","pubTime":"2025-04-29 22:28","pubTimestamp":1745936937,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日22时28分，Cardiff Oncology, Inc.股票出现异动，股价大幅下跌5.02%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体跌幅为1.37%。其相关个股中，Cyclacel Pharmaceuticals, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Zyversa Therapeutics, Inc.、Onconetix, Inc.、Ibio, Inc.较为活跃，换手率分别为145.32%、94.10%、32.50%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Spruce Biosciences, Inc.、Ibio, Inc.，振幅分别为50.68%、41.73%、33.33%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429222858974a4a52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429222858974a4a52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRDF","BK4139"],"gpt_icon":0},{"id":"2529682289","title":"Cardiff Oncology, Inc.盘中异动 早盘股价大涨6.23%报3.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529682289","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529682289?lang=zh_cn&edition=full","pubTime":"2025-04-23 21:30","pubTimestamp":1745415056,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时30分，Cardiff Oncology, Inc.股票出现异动，股价大幅拉升6.23%。截至发稿，该股报3.24美元/股，成交量2.5579万股，换手率0.04%，振幅0.00%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042321305694dfa6a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042321305694dfa6a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRDF","BK4139"],"gpt_icon":0},{"id":"2529581220","title":"Cardiff Oncology, Inc.盘中异动 早盘股价大涨5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529581220","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529581220?lang=zh_cn&edition=full","pubTime":"2025-04-22 21:58","pubTimestamp":1745330322,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日21时58分，Cardiff Oncology, Inc.股票出现波动，股价快速上涨5.32%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体涨幅为1.05%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504222158429740c112&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504222158429740c112&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRDF","BK4139"],"gpt_icon":0},{"id":"2528740502","title":"Cardiff Oncology, Inc.盘中异动 快速下跌5.10%报2.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528740502","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528740502?lang=zh_cn&edition=full","pubTime":"2025-04-17 03:23","pubTimestamp":1744831438,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日03时23分，Cardiff Oncology, Inc.股票出现波动，股价大幅下跌5.10%。截至发稿，该股报2.79美元/股，成交量104.65万股，换手率1.57%，振幅8.33%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体跌幅为1.97%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417032359a45b79fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417032359a45b79fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRDF","BK4139"],"gpt_icon":0},{"id":"2527175334","title":"Cardiff Oncology, Inc.盘中异动 早盘股价大涨5.02%报2.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527175334","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527175334?lang=zh_cn&edition=full","pubTime":"2025-04-15 21:35","pubTimestamp":1744724125,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日21时35分，Cardiff Oncology, Inc.股票出现波动，股价快速上涨5.02%。截至发稿，该股报2.93美元/股，成交量9.6996万股，换手率0.15%，振幅6.28%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504152135259738a687&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504152135259738a687&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRDF","BK4139"],"gpt_icon":0},{"id":"2527649181","title":"Cardiff Oncology, Inc.盘中异动 早盘急速拉升5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527649181","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527649181?lang=zh_cn&edition=full","pubTime":"2025-04-14 21:32","pubTimestamp":1744637530,"startTime":"0","endTime":"0","summary":"北京时间2025年04月14日21时32分，Cardiff Oncology, Inc.股票出现异动，股价急速拉升5.26%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.63%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Third Harmonic Bio, Inc.、Theratechnologies Inc.涨幅较大，Aditxt, Inc.、Processa Pharmaceuticals, Inc.、Soligenix, Inc.较为活跃，换手率分别为273.88%、131.61%、86.76%，振幅较大的相关个股有Artelo Biosciences, Inc.、Silence Therapeutics Plc、Verve Therapeutics, Inc.，振幅分别为13.38%、10.98%、10.12%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504142132109737839e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504142132109737839e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRDF"],"gpt_icon":0},{"id":"2526617661","title":"Cardiff Oncology, Inc.盘中异动 快速拉升5.04%报2.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526617661","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2526617661?lang=zh_cn&edition=full","pubTime":"2025-04-12 02:58","pubTimestamp":1744397929,"startTime":"0","endTime":"0","summary":"北京时间2025年04月12日02时58分，Cardiff Oncology, Inc.股票出现波动，股价快速拉升5.04%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体涨幅为1.74%。其相关个股中，Protagenic Therapeutics Inc C/Wts 26/04/2026 、Portage Biotech Inc.、Theratechnologies Inc.涨幅较大，Hepion Pharmaceuticals, Inc.、Portage Biotech Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为2137.62%、1782.97%、404.41%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Portage Biotech Inc.、Theratechnologies Inc.，振幅分别为193.75%、156.27%、77.44%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412025849aa2c6d36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412025849aa2c6d36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRDF","BK4139"],"gpt_icon":0},{"id":"2518847203","title":"Cardiff Oncology, Inc.盘中异动 下午盘快速下挫5.19%报3.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518847203","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518847203?lang=zh_cn&edition=full","pubTime":"2025-03-11 01:11","pubTimestamp":1741626690,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日01时11分，Cardiff Oncology, Inc.股票出现波动，股价快速跳水5.19%。截至发稿，该股报3.66美元/股，成交量38.3547万股，换手率0.58%，振幅5.19%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.82%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311011130a26a766f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311011130a26a766f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRDF"],"gpt_icon":0},{"id":"2517452649","title":"Cardiff Oncology, Inc.2024财年实现净利润-45.43百万美元，同比减少9.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517452649","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517452649?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:00","pubTimestamp":1741363258,"startTime":"0","endTime":"0","summary":"3月8日，Cardiff Oncology, Inc.公布财报，公告显示公司2024财年净利润为-45.43百万美元，同比减少9.63%；其中营业收入为683000.00美元，同比增加39.96%，每股基本收益为-0.95美元。从资产负债表来看，Cardiff Oncology, Inc.总负债14.24百万美元，其中短期债务710000.00美元，资产负债比为6.83，流动比率为7.08。机构评级：截至2025年3月8日，当前有4家机构对Cardiff Oncology, Inc.目标价做出预测，其中目标均价为14.25美元，其中最低目标价为10.00美元，最高目标价为20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000249a2647fc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000249a2647fc8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRDF"],"gpt_icon":0},{"id":"2517161846","title":"Cardiff Oncology, Inc.盘中异动 早盘大幅下挫5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517161846","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517161846?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:35","pubTimestamp":1741271739,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时35分，Cardiff Oncology, Inc.股票出现异动，股价急速下挫5.15%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.62%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223539963c4db0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223539963c4db0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRDF"],"gpt_icon":0},{"id":"2517946697","title":"Cardiff Oncology, Inc.盘中异动 急速上涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517946697","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517946697?lang=zh_cn&edition=full","pubTime":"2025-03-05 23:32","pubTimestamp":1741188766,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日23时32分，Cardiff Oncology, Inc.股票出现异动，股价急速拉升5.09%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体涨幅为1.20%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305233246abe9c451&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305233246abe9c451&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRDF","BK4139"],"gpt_icon":0},{"id":"2516559796","title":"Cardiff Oncology, Inc.盘中异动 快速下挫5.07%报4.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516559796","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516559796?lang=zh_cn&edition=full","pubTime":"2025-03-04 00:12","pubTimestamp":1741018338,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日00时12分，Cardiff Oncology, Inc.股票出现波动，股价大幅跳水5.07%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Radiopharm Theranostics Limited涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为3454.38%、151.02%、139.72%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Radiopharm Theranostics Limited，振幅分别为206.20%、70.53%、53.50%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304001219abe65461&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304001219abe65461&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRDF"],"gpt_icon":0},{"id":"2514320288","title":"Cardiff Oncology, Inc.盘中异动 大幅上涨5.30%报4.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514320288","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514320288?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:35","pubTimestamp":1740753340,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时35分，Cardiff Oncology, Inc.股票出现异动，股价急速上涨5.30%。截至发稿，该股报4.28美元/股，成交量15.4379万股，换手率0.23%，振幅3.75%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223540abe0ebfa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223540abe0ebfa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRDF"],"gpt_icon":0},{"id":"1118930078","title":"Cardiff Oncology第四季度GAAP每股收益$(0.21)优于预期$(0.24)，销售额$151.00K优于预期$94.17K","url":"https://stock-news.laohu8.com/highlight/detail?id=1118930078","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118930078?lang=zh_cn&edition=full","pubTime":"2025-02-28 05:38","pubTimestamp":1740692305,"startTime":"0","endTime":"0","summary":"Cardiff Oncology报告季度每股亏损$，优于分析师一致预期的$，增长了12.5%。与去年同期的销售额$156.00千相比下降了3.21%。以上内容来自Benzinga Earnings专栏，原文如下：Cardiff Oncology  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 12.5 percent. This is unchanged from the same period last year.  The company reported quarterly sales of $151.00 thousand which beat the analyst consensus estimate of $94.17 thousand by 60.35 percent.  This is a 3.21 percent decrease over sales of $156.00 thousand the same period last","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Cardiff Oncology第四季度GAAP每股收益$(0.21)优于预期$(0.24)，销售额$151.00K优于预期$94.17K","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRDF"],"gpt_icon":0},{"id":"2514163386","title":"Cardiff Oncology, Inc.盘中异动 早盘股价大跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514163386","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514163386?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:57","pubTimestamp":1740668275,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时57分，Cardiff Oncology, Inc.股票出现波动，股价快速下跌5.16%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体涨幅为1.01%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227225755989515c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227225755989515c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRDF"],"gpt_icon":0},{"id":"2514517328","title":"Cardiff Oncology, Inc.盘中异动 快速上涨5.20%报4.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514517328","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514517328?lang=zh_cn&edition=full","pubTime":"2025-02-26 23:12","pubTimestamp":1740582765,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日23时12分，Cardiff Oncology, Inc.股票出现异动，股价快速上涨5.20%。截至发稿，该股报4.45美元/股，成交量10.325万股，换手率0.16%，振幅4.96%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226231245963157ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226231245963157ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRDF","BK4139"],"gpt_icon":0},{"id":"2513262290","title":"Cardiff Oncology, Inc.盘中异动 大幅拉升5.11%报4.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513262290","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513262290?lang=zh_cn&edition=full","pubTime":"2025-02-22 01:00","pubTimestamp":1740157242,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日01时00分，Cardiff Oncology, Inc.股票出现异动，股价急速拉升5.11%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.44%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Invivyd, Inc.、Osr Holdings, Inc.涨幅较大，Nkgen Biotech, Inc.、Aditxt, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为235.52%、182.05%、124.79%，振幅较大的相关个股有Osr Holdings, Inc.、Osr Holdings Inc C/Wts 09/02/2028 、Nkgen Biotech, Inc.，振幅分别为72.46%、57.50%、48.35%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222010043a24ed09c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222010043a24ed09c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRDF"],"gpt_icon":0},{"id":"2512516486","title":"Cardiff Oncology, Inc.盘中异动 早盘股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512516486","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512516486?lang=zh_cn&edition=full","pubTime":"2025-02-19 23:23","pubTimestamp":1739978612,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日23时23分，Cardiff Oncology, Inc.股票出现异动，股价大幅拉升5.19%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.51%。其相关个股中，Osr Holdings, Inc.、Osr Holdings Inc C/Wts 02/09/2028 、Immunitybio, Inc.涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为432.79%、233.59%、146.58%，振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Osr Holdings, Inc.、Allogene Therapeutics, Inc.，振幅分别为207.68%、159.49%、36.97%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219232332a24c062e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219232332a24c062e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRDF","BK4139"],"gpt_icon":0},{"id":"2512165535","title":"Cardiff Oncology, Inc.盘中异动 快速拉升5.94%报4.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512165535","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512165535?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:35","pubTimestamp":1739889302,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时35分，Cardiff Oncology, Inc.股票出现异动，股价大幅拉升5.94%。截至发稿，该股报4.55美元/股，成交量4.606万股，换手率0.07%，振幅2.11%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223502abd3affe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223502abd3affe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRDF","BK4139"],"gpt_icon":0},{"id":"2511757251","title":"Cardiff Oncology, Inc.盘中异动 股价大跌5.18%报4.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511757251","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511757251?lang=zh_cn&edition=full","pubTime":"2025-02-14 04:03","pubTimestamp":1739477008,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日04时03分，Cardiff Oncology, Inc.股票出现异动，股价急速下跌5.18%。截至发稿，该股报4.12美元/股，成交量51.3894万股，换手率0.77%，振幅5.99%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体涨幅为1.06%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021404032898846c13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021404032898846c13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRDF"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cardiffoncology.com","stockEarnings":[{"period":"1week","weight":-0.068},{"period":"1month","weight":-0.1274},{"period":"3month","weight":-0.3098},{"period":"6month","weight":-0.1451},{"period":"1year","weight":-0.3716},{"period":"ytd","weight":-0.3687}],"compareEarnings":[{"period":"1week","weight":0.0357},{"period":"1month","weight":-0.0087},{"period":"3month","weight":-0.0835},{"period":"6month","weight":-0.0289},{"period":"1year","weight":0.1047},{"period":"ytd","weight":-0.0538}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cardiff Oncology, Inc.于2002年4月26日在佛罗里达州注册成立。该公司是一家临床阶段的生物技术公司，利用PLK1抑制（一种经过充分验证的肿瘤药物靶点）开发跨越一系列未满足医疗需求的癌症的新疗法。该公司的目标是通过onvansertib、公司口服和高选择性PLK1抑制剂以及标准护理疗法的治疗组合来针对肿瘤脆弱性。","yearOnYearQuotes":[{"month":1,"riseRate":0.461538,"avgChangeRate":0.003183},{"month":2,"riseRate":0.461538,"avgChangeRate":0.297462},{"month":3,"riseRate":0.384615,"avgChangeRate":0.093514},{"month":4,"riseRate":0.307692,"avgChangeRate":-0.07213},{"month":5,"riseRate":0.416667,"avgChangeRate":0.036218},{"month":6,"riseRate":0.416667,"avgChangeRate":0.317983},{"month":7,"riseRate":0.461538,"avgChangeRate":-0.066363},{"month":8,"riseRate":0.615385,"avgChangeRate":0.117352},{"month":9,"riseRate":0.307692,"avgChangeRate":0.018925},{"month":10,"riseRate":0.461538,"avgChangeRate":-0.026835},{"month":11,"riseRate":0.384615,"avgChangeRate":0.037241},{"month":12,"riseRate":0.384615,"avgChangeRate":-0.030168}],"exchange":"NASDAQ","name":"Cardiff Oncology, Inc.","nameEN":"Cardiff Oncology, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cardiff Oncology, Inc.(CRDF)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cardiff Oncology, Inc.(CRDF)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cardiff Oncology, Inc.,CRDF,Cardiff Oncology, Inc.股票,Cardiff Oncology, Inc.股票老虎,Cardiff Oncology, Inc.股票老虎国际,Cardiff Oncology, Inc.行情,Cardiff Oncology, Inc.股票行情,Cardiff Oncology, Inc.股价,Cardiff Oncology, Inc.股市,Cardiff Oncology, Inc.股票价格,Cardiff Oncology, Inc.股票交易,Cardiff Oncology, Inc.股票购买,Cardiff Oncology, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cardiff Oncology, Inc.(CRDF)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cardiff Oncology, Inc.(CRDF)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况